Fosamax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objective: To find out the significance of bone turnover markers in management of osteoporotic patients and correlation to…
—Fosamax (Alendronate) is an approved drug widely prescribed for osteoporosis treatment and other bone damaging diseases. Fosamax…
Paget disease in clinical practice is rare. By its nature the disease represents the disorder of bone remodeling processes. The…
A district court judge in the United States has ruled that the drug maker Merck will not face the risk of “punitive damages” in…
VOLUME 26 NUMBER 4 APRIL 2008 NATURE BIOTECHNOLOGY Most osteoporosis therapies act by inhibiting osteoclast-mediated bone…
VOLUME 26 NUMBER 4 APRIL 2008 NATURE BIOTECHNOLOGY Most osteoporosis therapies act by inhibiting osteoclast-mediated bone…
The 10-year half-life of the bisphosphonate alendronate suggests that its efficacy might persist after discontinuation. To…
A 10-year study of daily oral alendronate (Fosamax) and a 7-year study of daily oral risedronate (Actonel) indicate that both…
Data are submitted on results of investigations designed to study mineral density of the osseous tissue in patients with…